[1] Lamagni T, Wloch C, Broughton K, et al. Assessing the added value of group B Streptococcus maternal immunisation in preventing maternal infection and fetal harm: population surveillance study [J]. BJOG, 2022, 129(2):233-240. DOI: 10.1111/1471-0528.16852.
[2] Schindler Y, Rahav G, Nissan I, et al. Group B Streptococcus serotypes associated with different clinical syndromes: asymptomatic carriage in pregnant women, intrauterine fetal death, and early onset disease in the newborn [J]. PLoS One, 2020, 15(12):e0244450. DOI: 10.1371/journal.pone.0244450.
[3] AlZuheiri STS, Dube R, Menezes G, et al. Clinical profile and outcome of group b streptococcal colonization in mothers and neonates in ras al khaimah, united arab emirates: a prospective observational study [J]. Saudi J Med Med Sci, 2021, 9(3):235-240. DOI: 10.4103/sjmms.sjmms_213_21.
[4] Gonçalves BP, Procter SR, Paul P, et al. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden [J]. Lancet Glob Health, 2022, 10(6): e807-e819. DOI: 10.1016/S2214-109X(22)00093-6.
[5] Kadambari S, Trotter CL, Heath PT, et al. Group B streptococcal disease in England (1998 - 2017): a population-based observational study [J]. Clin Infect Dis, 2021, 72(11):e791-e798. DOI: 10.1093/cid/ciaa1485.
[6] Tano S, Ueno T, Mayama M, et al. Relationship between vaginal group B streptococcus colonization in the early stage of pregnancy and preterm birth: a retrospective cohort study [J]. BMC Pregnancy Childbirth, 2021, 21(1):141. DOI: 10.1186/s12884-021-03624-9.
[7] Naumkina EVE, Kravchenko EN, Kuklina LV. Experience in the diagnosis of group B Streptococcus infections in pregnant women and newborns in a perinatal center [J]. Klin Lab Diagn, 2021, 66(12):755-759. DOI: 10.51620/0869-2084-2021-66-12-755-759.
[8] Khalil MR, Uldbjerg N, Thorsen PB, et al. Improvement of selection of pregnant women for intrapartum polymerase chain reaction screening for vaginal group B Streptococci (GBS) colonization by adding GBS urine screening at 35-37 weeks of pregnancy [J]. Int J Gynaecol Obstet, 2020, 151(1): 124-127. DOI: 10.1002/ijgo.13267.
[9] 中华医学会妇产科学分会感染性疾病协作组. 宫颈高级别鳞状上皮内病变专家共识[J]. 中华妇产科杂志, 2016, 51(10):721-723.
[10] Chiarot E, Spagnuolo A, Maccari S, et al. Protective effect of group B Streptococcus type-Ⅲ polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models [J]. Sci Rep, 2018, 8(1):2593. DOI: 10.1038/s41598-018- 20609-5.
[11] Cho CY, Tang YH, Chen YH, et al. Group B Streptococcal infection in neonates and colonization in pregnant women: an epidemiological retrospective analysis [J]. J Microbiol Immunol Infect, 2019, 52(2): 265-272. DOI: 10.1016/j.jmii.2017.08.004.
[12] Yao Z, Jiayin W, Xinyi Z, et al. Identification of group B streptococcus serotypes and genotypes in late pregnant women and neonates that are associated with neonatal early-onset infection in a south China population [J]. Front Pediatr, 2020, 8: 265. DOI: 10.3389/fped. 2020.00265.
[13] Haimbodi EL, Mukesi M, Moyo SR. Prevalence and molecular characterization of group B streptococcus in pregnant women from hospitals in Ohangwena and Oshikoto regions of Namibia [J]. BMC Microbiol, 2021, 21(1):224. DOI: 10.1186/s12866-021-02283-2.
[14] Hasperhoven GF, Al-Nasiry S, Bekker V, et al. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis [J]. BJOG, 2020, 127(6): 680-691. DOI: 10.1111/1471-0528.16085.
[15] Sama LF, Noubom M, Kenne C, et al. Group B Streptococcus colonisation, prevalence, associated risk factors and antimicrobial susceptibility pattern among pregnant women attending antenatal care at Dschang District Hospital, West Region of Cameroon: a hospital-based cross-sectional study [J]. Int J Clin Pract, 2021, 75(10): e14683. DOI: 10.1111/ijcp.14683.
[16] Carreras-Abad C, To KN, Ramkhelawon L, et al. Detection of group B streptococcus colonisation in pregnant women: comparison of two different culture methods and study of antimicrobial resistance patterns [J]. J Infect, 2021, 82(5):186-230. DOI: 10.1016/j.jinf.2021.01.001.
[17] Yadeta TA, Worku A, Egata G, et al. Maternal group B Streptococcus recto vaginal colonization increases the odds of stillbirth: evidence from Eastern Ethiopia [J]. BMC Pregnancy Childbirth, 2018, 18(1): 410. DOI: 10.1186/s12884-018-2044-2.
[18] de Gier B, van Kassel MN, Sanders EAM, et al. Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands [J]. PLoS One, 2019, 14(5):e0216749. DOI: 10.1371/journal.pone.0216749.
[19] Absalon J, Segall N, Block SL, et al. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial [J]. Lancet Infect Dis, 2021, 21(2): 263-274. DOI: 10.1016/S1473-3099(20)30478-3.
|